BOOM
Citations are updated once a week. Recently added citations may not appear.
| Context | Citation |
|---|---|
| Metha family {Mint} - Staphylococcus aureus H70821 |
👶
Evaluation of Phenolic Compounds and Antioxidant and Antimicrobial Activities of Some Common Herbs. International journal of analytical chemistry (Int J Anal Chem ) Vol: 2017 Issue Pages: 3475738 Pub: 2017 Epub: 2017 Feb 16 Authors Abdul Qadir M , Shahzadi SK , Bashir A , Munir A , Shahzad S , Html Article Publication |
| Metha family {Mint} - Staphylococcus aureus H70821 |
👶
Comparative Evaluation of Different Mint Species Based on Their In Vitro Antioxidant and Antibacterial Effect. Plants (Basel, Switzerland) (Plants (Basel) ) Vol: 14 Issue 1 Pages: Pub: 2025 Jan 2 Epub: 2025 Jan 2 Authors Sfaxi A , Tavaszi-Sárosi S , Flórián K , Patonay K , Radácsi P , Juhász Á , Html Article Publication |
| Metha family {Mint} - Staphylococcus aureus H70821 |
👶
Screening of the antibacterial effects of a variety of essential oils on respiratory tract pathogens, using a modified dilution assay method. Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy (J Infect Chemother ) Vol: 7 Issue 4 Pages: 251-4 Pub: 2001 Dec Epub: Authors Inouye S , Yamaguchi H , Takizawa T , Publication |
| Metha family {Mint} - Staphylococcus aureus H70821 |
👶
Inhibition by the essential oils of peppermint and spearmint of the growth of pathogenic bacteria. Microbios (Microbios ) Vol: 106 Suppl 1 Issue Pages: 31-9 Pub: 2001 Epub: Authors Imai H , Osawa K , Yasuda H , Hamashima H , Arai T , Sasatsu M , |
| Metha family {Mint} - Staphylococcus aureus H70821 |
👶
Green synthesis of tea Ag nanocomposite hydrogels via mint leaf extraction for effective antibacterial activity. Journal of biomaterials science. Polymer edition (J Biomater Sci Polym Ed ) Vol: 28 Issue 14 Pages: 1588-1602 Pub: 2017 Oct Epub: 2017 Jun 22 Authors Jayaramudu T , Varaprasad K , Raghavendra GM , Sadiku ER , Mohana Raju K , Amalraj J , Publication |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
